VJHemOnc is committed to improving our service to you

COMy 2019 | CAR-T cells for myeloma: experience from China

VJHemOnc is committed to improving our service to you

He Huang

CAR T-cell therapy stands as a topic of great interest and debate in multiple myeloma (MM), with many trials ongoing around the world. He Huang, MD, PhD, Zhejiang University School of Medicine, Zhejiang, China, presents an update on the CAR-T experience in China, discussing ongoing trials and developments in MM. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter